Genz-123346 free base是 GL1 合成酶的抑制剂,能够阻止神经酰胺转化为 GL1,其 GM1 抑制的 IC50 为 14 nM。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Genz-123346 free base is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1 and IC50 for GM1 inhibition is 14 nM. |
Concentration | Treated Time | Description | References | |
Huh7 cells | 5 µM | 6 days | increased numbers of apoptotic and necrotic cells | Int J Mol Sci. 2024 Dec 31;26(1):304 |
Hepa 1-6 cells | 5 µM | 6 days | increased numbers of apoptotic and necrotic cells | Int J Mol Sci. 2024 Dec 31;26(1):304 |
Neonatal rat left ventricular myocytes (NRVMs) | 100 μM | 48 hours | Establish a cardiomyocyte hypertrophy model, results showed significant increase in mRNA expression of ANP, BNP, and β-MHC. | Front Pharmacol. 2024 Oct 1;15:1409625 |
HCT116 cells | 5 µM | 4 days | 5 µM Genz significantly inhibited the cell cycle of HCT116 cells | Int J Mol Sci. 2021 Sep 29;22(19):10539 |
Lovo cells | 1 µM and 5 µM | 4 days | Genz treatment led to cell cycle arrest in G0/G1 phase and decreased cell numbers in S and G2/M phases in Lovo cells | Int J Mol Sci. 2021 Sep 29;22(19):10539 |
Mouse primary microglia | 10 µM | 72 h | Reduction in GM1 and GD1a levels and increased TNF mRNA expression upon LPS stimulation | J Neuroinflammation. 2022 Jan 6;19(1):9 |
BV2 cells | 5-15 µM | 72 h | Inhibition of UGCG activity, reduction in cellular GM1 and GD1a levels, and enhanced inflammatory response upon LPS stimulation | J Neuroinflammation. 2022 Jan 6;19(1):9 |
Dopaminergic neuronal cultures (DNCs) | 5 μM | 3–5 days | Reduced mTORC1 activity and increased TFEB expression | Front Neurosci. 2023 Jun 2;17:1152503 |
Neuronal Progenitor cells (NPCs) | 5 μM | 3–5 days | Inhibition of sphingolipid biosynthesis, reducing mTORC1 kinase activity and increasing TFEB levels | Front Neurosci. 2023 Jun 2;17:1152503 |
MDCK cells | 10 μM | 8 hours | To test the antiviral activity of GCS inhibitors against influenza virus A/PR/8/34 (H1N1), results showed that GZ-346 significantly inhibited viral RNA release | J Biol Chem. 2021 Jan-Jun;296:100470 |
Vero E6 cells | 10 μM | 24 hours | To test the antiviral activity of GCS inhibitors against SARS-CoV-2, results showed that GZ-346 significantly inhibited viral release | J Biol Chem. 2021 Jan-Jun;296:100470 |
Administration | Dosage | Frequency | Description | References | ||
Mice | Jck mice (model of human nephronophthisis) | Oral | 0.1% or 0.2% in feed | From 4 to 9 weeks of age | Genz-123346 treatment resulted in a dose-dependent reduction of renal GlcCer and GM3 levels that translated into effective inhibition of cystic disease | Nat Med. 2010 Jul;16(7):788-92 |
Mice | Experimental colon cancer model | Oral | 0.225% Genz | 10 weeks | Genz reduced the incidence of experimental colon cancer, particularly the growth of colorectal adenomas | Int J Mol Sci. 2021 Sep 29;22(19):10539 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.39mL 0.48mL 0.24mL |
11.95mL 2.39mL 1.19mL |
23.89mL 4.78mL 2.39mL |
CAS号 | 491833-30-8 |
分子式 | C24H38N2O4 |
分子量 | 418.57 |
SMILES Code | CCCCCCCCC(N[C@H](CN1CCCC1)[C@@H](C2=CC=C3OCCOC3=C2)O)=O |
MDL No. | MFCD22419854 |
别名 | Genz-123346 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, store in freezer, under -20°C |
溶解方案 |
DMSO: 105 mg/mL(250.85 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|